マウスモデル市場：タイプ、技術、治療領域、用途別-2025-2030年の世界予測

マウスモデル市場は、2023年に14億9,000万米ドルと評価され、2024年には16億1,000万米ドルに達すると予測され、CAGR 8.34％で成長し、2030年には26億1,000万米ドルになると予測されています。

マウスモデル市場は、生物医学研究における遺伝子操作マウスの使用を包含しており、ヒトの疾病の理解、医薬品開発、治療試験のための不可欠なツールとして深い範囲を提供しています。これらのモデルはヒトと遺伝的に類似しているため極めて重要であり、がん、心血管疾患、代謝性疾患などに関する洞察を容易にしています。マウスモデルの必要性は、ヒトの疾患表現型をモデル化する能力によって強調され、その結果、トランスレーショナル研究や前臨床研究において貴重な存在となっています。用途別では、製薬、バイオテクノロジー、学術研究機関などで採用されており、エンドユーザーの範囲は創薬、毒性学、遺伝子研究などに及ぶ。この市場の成長を牽引しているのは、ゲノム研究に対する政府資金の増加、個別化医療に対する需要の高まり、CRISPRやその他の遺伝子工学技術の進歩です。慢性疾患の急増も、効率的な動物モデルの必要性を高めています。しかし、動物実験に関する倫理的懸念は、厳しい規制の枠組みとともに大きな課題となっています。さらに、遺伝子工学的モデルの開発に伴う複雑さや維持コストの高さが、市場開拓の妨げとなる可能性もあります。チャンスは、より洗練されたヒト化マウスモデルの開発と、より正確なデータを収集するための画像診断・監視技術の強化にあります。データ共有のためのオープンアクセスプラットフォームを採用することで、より広範な共同研究が促進され、進歩が加速される可能性があります。非侵襲的イメージング技術とデジタル病理学の革新は、研究開発にとって有力な分野です。市場力学は非常にダイナミックで競争が激しく、モデルの精度を高め、倫理的な懸念を軽減する技術革新が常に重視されています。企業にとっては、AIを活用したデータ解析のような新たな動向の取り込みや、臨床研究インフラが成長する未開拓地域への進出が大きな成長をもたらす可能性があります。全体として、市場は課題に直面しているもの、効率的な研究モデルに対する継続的な需要は、力強い成長の可能性をもたらしています。

市場力学：急速に進化するマウスモデル市場の主要市場インサイトを公開

マウスモデル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 薬物試験や免疫疾患研究へのマウスモデルの利用拡大
  • 医薬品の研究開発活動の急増に伴う投資と助成金の増加
• 市場抑制要因
  • マウスモデル開発に伴う高コスト
• 市場機会
  • マウスモデリングにおけるAIとMLの導入の台頭
  • マウスモデル作製におけるCRISPR-Cas9技術の登場
• 市場の課題
  • 研究における動物の倫理的使用を考慮した厳しい規制と法律

ポーターのファイブフォース：マウスモデル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マウスモデル市場における外部からの影響の把握

外部マクロ環境要因は、マウスモデル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析マウスモデル市場における競合情勢の把握

マウスモデル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスマウスモデル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マウスモデル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨マウスモデル市場における成功への道筋を描く

マウスモデル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 薬物試験や免疫疾患の調査におけるマウスモデルの利用拡大
    • 投資と助成金の増加と医薬品研究開発活動の急増
  • 抑制要因
    • マウスモデルの開発に伴う高コスト
  • 機会
    • マウスモデリングにおけるAIとMLの新たな実装
    • マウスモデリングにおけるCRISPR-Cas9技術の登場
  • 課題
    • 調査における動物の倫理的使用を考慮した厳格な規制と法律
• 市場セグメンテーション分析
  • タイプ：遺伝子治療の結果を評価するための遺伝子操作マウスの重要性の高まり
  • 応用：臨床試験前に治療効果と安全性プロファイルを調査するためのマウスモデルの採用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 マウスモデル市場：タイプ別

• 条件付け/外科手術により改変されたマウス
• 遺伝子組み換えマウス
• ハイブリッド/コンジェニックマウス
• 近交系マウス
• 近交系マウス

第7章 マウスモデル市場：技術別

• クリスパー/CAS9
• 胚性幹細胞注入
• マイクロインジェクション
• 核移植

第8章 マウスモデル市場治療領域別

• 心血管疾患
• 免疫学
• 代謝性疾患
• 神経学
• 腫瘍学

第9章 マウスモデル市場：用途別

• 医薬品の発見と開発
• パーソナライズ医療
• 調査アプリケーション

第10章 南北アメリカのマウスモデル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のマウスモデル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのマウスモデル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • バイオサイトジェンがRenMiceシリーズを正式に発売
  • NeoMabのご紹介：GemPharmatechの革新的な抗体遺伝子ヒト化マウスモデル
  • 吠えるネズミ：中国の科学者が遺伝子を完全に再プログラムした初の哺乳類を作製
  • UCLAの研究者らがハンチントン病の初のヒトゲノムトランスジェニックマウスモデルを開発
• 戦略分析と提言

企業一覧

• Applied StemCell, Inc.
• Aragen Life Sciences Ltd.
• Biocytogen Boston Corporation
• Charles River Laboratories International, Inc.
• CompareNetworks, Inc.
• Creative Biolabs.
• Crown Bioscience by JSR Life Sciences, LLC
• Cyagen US Inc. by PolyGene AG
• Envigo by Inotiv, Inc.
• GenOway
• Harbour BioMed
• Horizon Discovery Ltd. by PerkinElmer, Inc.
• inGenious Targeting Laboratory, Inc.
• ITR Laboratories Canada
• Janvier Labs
• Marshall BioResources
• MD Biosciences
• Mirimus, Inc.
• Oncodesign, SA
• Ozgene Pty Ltd.
• PhoenixBio Co., Ltd.
• Shanghai Model Organisms Center, Inc.
• Taconic Biosciences, Inc.
• The Jackson Laboratory
• TransCure bioServices
• Translational Drug Development, LLC
• Transnetyx, Inc.
• Urosphere SAS
• Vivo Bio Tech Ltd.
• XenOPAT SL by Bellvitge Biomedical Research Institute

LIST OF FIGURES

• FIGURE 1. MICE MODEL MARKET RESEARCH PROCESS
• FIGURE 2. MICE MODEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICE MODEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICE MODEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MICE MODEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MICE MODEL MARKET DYNAMICS
• TABLE 7. GLOBAL MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MICE MODEL MARKET SIZE, BY CONDITIONED/SURGICALLY MODIFIED MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MICE MODEL MARKET SIZE, BY GENETICALLY ENGINEERED MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MICE MODEL MARKET SIZE, BY HYBRID/CONGENIC MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MICE MODEL MARKET SIZE, BY INBRED MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MICE MODEL MARKET SIZE, BY OUTBRED MICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MICE MODEL MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MICE MODEL MARKET SIZE, BY EMBRYONIC STEM CELL INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MICE MODEL MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MICE MODEL MARKET SIZE, BY NUCLEAR TRANSFER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MICE MODEL MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MICE MODEL MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MICE MODEL MARKET SIZE, BY METABOLIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MICE MODEL MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL MICE MODEL MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL MICE MODEL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL MICE MODEL MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL MICE MODEL MARKET SIZE, BY RESEARCH APPLICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. CANADA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 44. CANADA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES MICE MODEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. CHINA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 66. CHINA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. INDIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 70. INDIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA MICE MODEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 138. ITALY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 139. ITALY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. POLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 155. POLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 158. QATAR MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 159. QATAR MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM MICE MODEL MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM MICE MODEL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM MICE MODEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. MICE MODEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 197. MICE MODEL MARKET, FPNV POSITIONING MATRIX, 2023

The Mice Model Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.61 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 2.61 billion by 2030.

The mice model market encompasses the use of genetically engineered mice in biomedical research, offering a profound scope as an essential tool for understanding human diseases, drug development, and therapeutic testing. These models are pivotal due to their genetic similarities with humans, facilitating insights into cancer, cardiovascular diseases, metabolic disorders, and more. The necessity of mice models is underscored by their ability to model human disease phenotypes, thus becoming invaluable in translational and preclinical research. Application-wise, they are employed across pharmaceuticals, biotechnology, and academic research institutions, with end-user scope spanning drug discovery, toxicology, and genetic research. Growth in this market is driven by increased government funding for genomic research, rising demand for personalized medicine, and advancements in CRISPR and other genetic engineering technologies. The surge in chronic disease prevalence also bolsters the need for efficient animal models. However, ethical concerns regarding animal testing, along with stringent regulatory frameworks, present significant challenges. Additionally, the complexity involved in developing genetically engineered models and the high cost of maintenance can hinder market expansion. Opportunities lie in developing more sophisticated humanized mice models and enhancing imaging and surveillance technologies to gather more precise data. Embracing open-access platforms for data sharing could foster broader collaborative research and accelerate advancements. Innovations in non-invasive imaging techniques and digital pathology are potent areas for research and development. The nature of the mice model market is highly dynamic and competitive, with continuous emphasis on innovations that enhance model accuracy and reduce ethical concerns. For businesses, tapping into emerging trends like AI-driven data analysis and expanding into untapped regions with growing clinical research infrastructure may yield substantial growth. Overall, while the market faces challenges, the continual demand for efficient research models offers robust growth potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mice Model Market

The Mice Model Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Escalating use of mice models for drug testing and research of immune disease
  • Rising investments and grants coupled with surging pharmaceutical R&D activities
• Market Restraints
  • High costs associated with development of mice models
• Market Opportunities
  • Emerging implementation of AI and ML in mice modeling
  • Advent of CRISPR-Cas9 technology in mice modeling
• Market Challenges
  • Stringent regulations and laws considering the ethical use of animals in research

Porter's Five Forces: A Strategic Tool for Navigating the Mice Model Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mice Model Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mice Model Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mice Model Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mice Model Market

A detailed market share analysis in the Mice Model Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mice Model Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mice Model Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mice Model Market

A strategic analysis of the Mice Model Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mice Model Market, highlighting leading vendors and their innovative profiles. These include Applied StemCell, Inc., Aragen Life Sciences Ltd., Biocytogen Boston Corporation, Charles River Laboratories International, Inc., CompareNetworks, Inc., Creative Biolabs., Crown Bioscience by JSR Life Sciences, LLC, Cyagen US Inc. by PolyGene AG, Envigo by Inotiv, Inc., GenOway, Harbour BioMed, Horizon Discovery Ltd. by PerkinElmer, Inc., inGenious Targeting Laboratory, Inc., ITR Laboratories Canada, Janvier Labs, Marshall BioResources, MD Biosciences, Mirimus, Inc., Oncodesign, SA, Ozgene Pty Ltd., PhoenixBio Co., Ltd., Shanghai Model Organisms Center, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, TransCure bioServices, Translational Drug Development, LLC, Transnetyx, Inc., Urosphere SAS, Vivo Bio Tech Ltd., and XenOPAT SL by Bellvitge Biomedical Research Institute.

Market Segmentation & Coverage

This research report categorizes the Mice Model Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Conditioned/Surgically Modified Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Inbred Mice, and Outbred Mice.
• Based on Technology, market is studied across CRISPR/CAS9, Embryonic Stem Cell Injection, Microinjection, and Nuclear Transfer.
• Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Immunology, Metabolic Diseases, Neurology, and Oncology.
• Based on Application, market is studied across Drug Discovery & Development, Personalized Medicine, and Research Application.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Escalating use of mice models for drug testing and research of immune disease
    • 5.1.1.2. Rising investments and grants coupled with surging pharmaceutical R&D activities
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with development of mice models
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging implementation of AI and ML in mice modeling
    • 5.1.3.2. Advent of CRISPR-Cas9 technology in mice modeling
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations and laws considering the ethical use of animals in research
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing significance of genetically engineered mice for evaluating gene therapy outcomes
  • 5.2.2. Application: Rising adoption of mice models to explore therapeutic efficacy and safety profiles before clinical trials
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Mice Model Market, by Type

• 6.1. Introduction
• 6.2. Conditioned/Surgically Modified Mice
• 6.3. Genetically Engineered Mice
• 6.4. Hybrid/Congenic Mice
• 6.5. Inbred Mice
• 6.6. Outbred Mice

7. Mice Model Market, by Technology

• 7.1. Introduction
• 7.2. CRISPR/CAS9
• 7.3. Embryonic Stem Cell Injection
• 7.4. Microinjection
• 7.5. Nuclear Transfer

8. Mice Model Market, by Therapeutic Area

• 8.1. Introduction
• 8.2. Cardiovascular Diseases
• 8.3. Immunology
• 8.4. Metabolic Diseases
• 8.5. Neurology
• 8.6. Oncology

9. Mice Model Market, by Application

• 9.1. Introduction
• 9.2. Drug Discovery & Development
• 9.3. Personalized Medicine
• 9.4. Research Application

10. Americas Mice Model Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Mice Model Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Mice Model Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Biocytogen Officially Launches RenMice Series
  • 13.3.2. Introducing NeoMab: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model
  • 13.3.3. A Mouse That Roars: Chinese Scientists Create The First Mammal With Fully Reprogrammed Genes
  • 13.3.4. UCLA Researchers Develop First Human Genomic Transgenic Mouse Model Of Huntington's Disease
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Applied StemCell, Inc.
• 2. Aragen Life Sciences Ltd.
• 3. Biocytogen Boston Corporation
• 4. Charles River Laboratories International, Inc.
• 5. CompareNetworks, Inc.
• 6. Creative Biolabs.
• 7. Crown Bioscience by JSR Life Sciences, LLC
• 8. Cyagen US Inc. by PolyGene AG
• 9. Envigo by Inotiv, Inc.
• 10. GenOway
• 11. Harbour BioMed
• 12. Horizon Discovery Ltd. by PerkinElmer, Inc.
• 13. inGenious Targeting Laboratory, Inc.
• 14. ITR Laboratories Canada
• 15. Janvier Labs
• 16. Marshall BioResources
• 17. MD Biosciences
• 18. Mirimus, Inc.
• 19. Oncodesign, SA
• 20. Ozgene Pty Ltd.
• 21. PhoenixBio Co., Ltd.
• 22. Shanghai Model Organisms Center, Inc.
• 23. Taconic Biosciences, Inc.
• 24. The Jackson Laboratory
• 25. TransCure bioServices
• 26. Translational Drug Development, LLC
• 27. Transnetyx, Inc.
• 28. Urosphere SAS
• 29. Vivo Bio Tech Ltd.
• 30. XenOPAT SL by Bellvitge Biomedical Research Institute